Guess HM, Arrighi HM, Metter EJ, et al. Cumulative prevalence of prostatism
matches the autopsy prevalence of benign prostatic hyperplasia. Prostate
1990;17:241.
2.
Carson CC. Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education. Int J Impot
Res2002;14(Suppl. 1):S29–34.
3.
Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol
1994;151(1):54–61.
4.
Blanker MH, Bohnen AM, Groeneveld FPMJ, et al.
Correlates for erectile and ejaculatory dysfunction in older Dutch men:
A community-based study. Journal of the American Geriatrics Society
2001;49(4):436–42.
5.
Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E, et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male(MSAM-7).Eur Urol
2003;44(6):637–49.
6.
McVary KT, Foley J, Slawin K, Kusek J, MTOPS Study Group. The long term effects of doxazosin, finasteride, and the combination on sexual function in men participating in the MTOPS Trial. J of Urol
2004;171(4) Abstract 1194.
7.
Li MK,Garcia LA, Rosen R. Lower urinary tract symptoms and male sexual dysfunction in Asia: a survey of ageing men from five Asian countries. BJU Int
2005;96,1339-54
8.
McVary KT. Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eru Urol 2005;47:838-45